Trial intelligence / Profile preview

Clotinab in Acute Myocardial Infarction

NCT03087539Phase 2Unknown

Sponsor
ISU Abxis Co., Ltd.
Start
May 2013
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Clotinab in acute myocardial infarction (AMI), sponsored by ISU Abxis Co., Ltd.. Status: unknown.

02

Drugs

Clotinab
03

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT03087539.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03087539.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call